http://rdf.ncbi.nlm.nih.gov/pubchem/reference/36386256

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 220
issn 0168-3659
pageRange 204-220
startingPage 204
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_264d18c3229667c7b1fcf997aca1431f
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_498f1af88d1cb15a4ef11876b876e264
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_bd8e58af21c4c7d5e47196ddf48e94bb
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_487baf6554eb36bb22c6138d90a7c50f
bibliographicCitation She W, Li H, Wang Z, Liu T, Zhao D, Guo Z, Liu Y, Liu Y. Site-specific controlled-release nanoparticles for immune reprogramming via dual metabolic inhibition against triple-negative breast cancer. J Control Release. 2024 Feb;366():204–20. doi: 10.1016/j.jconrel.2023.12.022. PMID: 38109945.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c52f9b798285500aaecb90a56255778a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_18052d239666a27ff3ecd8d01aeed1f8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fde99948e9ed0f1bb17642c3ea22a8fc
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f5c52c7402723e4c8c99144353ad2f2d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_52f85bc2b6cbe69ee8b266eff3548783
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_95aaa4fd7f103a632596bb351a0d1228
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4f0522cd484502b932c9e042cd4e8379
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e498209e7eb15cbdf09088949ff3dfd4
date 202402
identifier https://pubmed.ncbi.nlm.nih.gov/38109945
https://doi.org/10.1016/j.jconrel.2023.12.022
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21032
https://portal.issn.org/resource/ISSN/0168-3659
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Site-specific controlled-release nanoparticles for immune reprogramming via dual metabolic inhibition against triple-negative breast cancer
discusses http://id.nlm.nih.gov/mesh/M0005772
http://id.nlm.nih.gov/mesh/M0001483

Total number of triples: 29.